港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

泰德醫藥

40.640

+0.7401.85%

成交量：27.44萬

成交額：1,100.45萬

市值：57.71億

市盈率：85.85

高：41.540

開：39.400

低：38.680

收：39.900

52周最高：41.720

52周最低：28.100

股本：1.42億

香港流通股本：7,359.89萬

量比：0.80

換手率：0.37%

股息：- -

股息率：- -

每股收益(LYR):0.473

淨資產收益率：20.67%

總資產收益率：5.25%

市淨率：16.62

市盈率(LYR):85.85

市銷率: 11.98

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

泰德醫藥

交易所：

SEHK

成立時間：

2020

員工人數：

- -

公司地址：

No. 69, 12 Street,Qiantang District,Hangzhou,Zhejiang Province,China

官網：

http://www.medtideinc.com

郵編：

310018

電話：

- -

傳真：

- -

簡介：

泰德醫藥（浙江）股份有限公司是一家主要從事多肽的合約研究、開發和生產的中國公司。該公司主要提供合約研究機構（CRO）服務，即多肽新化學實體（NCE）發現合成、合約開發及生產機構（CDMO）服務即多肽化學、製造及控制（CMC）開發以及商業化生產。該公司的服務主要專註於向客戶提供活性藥物成分（APIs），而非藥品。該公司也為客戶提供多肽類藥物開發、生產、CMC申報支持服務。該公司主要在國內市場和海外市場開展業務。

董事

名稱

職位

徐琪

董事長，執行董事，薪酬委員會委員，提名委員會主席

李湘

執行董事

李湘莉

執行董事

Cheng Tao

執行董事

李玲梅

執行董事

朱迅

獨立非執行董事，薪酬委員會主席，審核委員會委員

於常海

獨立非執行董事，提名委員會委員，審核委員會委員

夏心晟

獨立非執行董事，薪酬委員會委員，提名委員會委員，審核委員會主席

吳一暉

非執行董事

顏喜亞

監事會主席，股東代表監事

吳海剛

股東代表監事

傅紅英

職工代表監事

股東

名稱

職位

徐琪

首席執行官

徐偉群

財務總監

李玲梅

董事會秘書，聯席公司秘書

李忠成

聯席公司秘書

Cheng Tao

首席商務官

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/03880/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"03880","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03880\",,,,,undefined,":{"symbol":"03880","market":"HK","secType":"STK","nameCN":"泰德醫藥","latestPrice":40.64,"timestamp":1755850090201,"preClose":39.9,"halted":0,"volume":274400,"delay":0,"floatShares":73598888,"shares":142000000,"eps":0.473384,"marketStatus":"未開盤","change":0.74,"latestTime":"08-22 16:08:10","open":39.4,"high":41.54,"low":38.68,"amount":11004524,"amplitude":0.071679,"askPrice":40.7,"askSize":3000,"bidPrice":40.64,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":0.376814,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1756085400000},"marketStatusCode":0,"adr":0,"listingDate":1751212800000,"exchange":"SEHK","adjPreClose":39.9,"openAndCloseTimeList":[[1755826200000,1755835200000],[1755838800000,1755849600000]],"volumeRatio":0.8004200453881892,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03880\",,,,,undefined,":{"symbol":"03880","floatShares":73598888,"roa":"5.25%","roe":"20.67%","lyrEps":0.473384,"volumeRatio":0.8004200453881892,"shares":142000000,"dividePrice":0,"high":41.54,"amplitude":0.071679,"preClose":39.9,"low":38.68,"week52Low":28.1,"pbRate":"16.62","psRate":"11.98","week52High":41.72,"institutionHeld":0,"latestPrice":40.64,"committee":-0.2,"eps":0.473384,"divideRate":0,"volume":274400,"delay":0,"ttmEps":0.376814,"open":39.4,"prevYearClose":30.6,"prevWeekClose":35.98,"prevMonthClose":35.7,"prevQuarterClose":30.8,"fiveDayClose":35.98,"twentyDayClose":33.9,"sixtyDayClose":30.6,"earningDate":1756396800000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03880\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03880\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03880\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03880\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03880","date":"2025-08-22","current":89.502411,"percent":1,"low":64.550519,"twenty":69.02331,"median":74.090002,"eighty":78.320217,"high":89.502411,"avg":74.609005,"sd":5.259838,"marketCap":5762752000},"quantilePoints":[{"date":"2025-06-27","current":64.550519,"twenty":64.550519,"median":64.550519,"eighty":64.550519,"marketCap":4183100000},{"date":"2025-07-04","current":69.032987,"twenty":66.795355,"median":68.595377,"eighty":69.313609,"marketCap":4473790000},{"date":"2025-07-11","current":68.445519,"twenty":67.311524,"median":68.276633,"eighty":68.994281,"marketCap":4431250000},{"date":"2025-07-18","current":76.171108,"twenty":67.389311,"median":68.984604,"eighty":75.214843,"marketCap":4927550000},{"date":"2025-07-25","current":74.03868,"twenty":67.965697,"median":71.906475,"eighty":74.616858,"marketCap":4807020000},{"date":"2025-08-01","current":77.026259,"twenty":68.377965,"median":73.828208,"eighty":76.342138,"marketCap":4970090000},{"date":"2025-08-08","current":73.611635,"twenty":68.565405,"median":73.719922,"eighty":75.214843,"marketCap":4761644000},{"date":"2025-08-15","current":78.991101,"twenty":68.906759,"median":73.83709,"eighty":76.342138,"marketCap":5101964000},{"date":"2025-08-22","current":89.502411,"twenty":69.02331,"median":74.090002,"eighty":78.320217,"marketCap":5762752000}],"updateTime":1756045389801},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":672607238,"yearFounded":2020,"address":"No. 69, 12 Street,Qiantang District,Hangzhou,Zhejiang Province,China","zipCode":"310018"},"stockCompanyDetail":{"websiteUrl":"http://www.medtideinc.com","stockEarnings":[{"period":"1week","weight":0.1295},{"period":"1month","weight":0.2095},{"period":"3month","weight":0.3281},{"period":"ytd","weight":0.3281}],"compareEarnings":[{"period":"1week","weight":0.0027},{"period":"1month","weight":-0.0078},{"period":"3month","weight":0.0736},{"period":"6month","weight":0.0793},{"period":"1year","weight":0.4364},{"period":"ytd","weight":0.2632}],"compareStock":{"symbol":"HSI","name":"恆生指數"},"description":"泰德醫藥（浙江）股份有限公司是一家主要從事多肽的合約研究、開發和生產的中國公司。該公司主要提供合約研究機構（CRO）服務，即多肽新化學實體（NCE）發現合成、合約開發及生產機構（CDMO）服務即多肽化學、製造及控制（CMC）開發以及商業化生產。該公司的服務主要專註於向客戶提供活性藥物成分（APIs），而非藥品。該公司也為客戶提供多肽類藥物開發、生產、CMC申報支持服務。該公司主要在國內市場和海外市場開展業務。","exchange":"SEHK","name":"泰德醫藥","nameEN":"MEDTIDE"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"03880\",market:\"HK\",,,undefined,":{"directors":[{"name":"徐琪","position":"董事長，執行董事，薪酬委員會委員，提名委員會主席"},{"name":"李湘","position":"執行董事"},{"name":"李湘莉","position":"執行董事"},{"name":"Cheng Tao","position":"執行董事"},{"name":"李玲梅","position":"執行董事"},{"name":"朱迅","position":"獨立非執行董事，薪酬委員會主席，審核委員會委員"},{"name":"於常海","position":"獨立非執行董事，提名委員會委員，審核委員會委員"},{"name":"夏心晟","position":"獨立非執行董事，薪酬委員會委員，提名委員會委員，審核委員會主席"},{"name":"吳一暉","position":"非執行董事"},{"name":"顏喜亞","position":"監事會主席，股東代表監事"},{"name":"吳海剛","position":"股東代表監事"},{"name":"傅紅英","position":"職工代表監事"}],"executives":[{"name":"徐琪","position":"首席執行官"},{"name":"徐偉群","position":"財務總監"},{"name":"李玲梅","position":"董事會秘書，聯席公司秘書"},{"name":"李忠成","position":"聯席公司秘書"},{"name":"Cheng Tao","position":"首席商務官"}]}}}